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Physical activity is key for successful ageing, but questions remain regarding the optimal physical 
activity pattern. We examined the cross-sectional association between physical activity and successful 
ageing using data on 3,749 participants (age range = 60–83years) of the Whitehall II study. The 
participants underwent a clinical assessment, completed a 20-item physical activity questionnaire, 
and wore a wrist-mounted accelerometer for 9 days. Successful ageing was defined as good cognitive, 
motor, and respiratory functioning, along with absence of disability, mental health problems, and 
major chronic diseases. Time spent in moderate-to-vigorous physical activity (MVPA) episodes 
assessed by accelerometer was classified as “short” (1–9.59 minutes) and “long” (≥10 minutes) bouts. 
Linear multivariate regression showed that successful agers (N = 789) reported 3.79 (95% confidence 
interval (CI): 1.39–6.19) minutes more daily MVPA than other participants. Accelerometer data 
showed this difference to be 3.40 (95% CI:2.44–4.35) minutes for MVPA undertaken in short bouts, 
4.16 (95% CI:3.11–5.20) minutes for long bouts, and 7.55 (95% CI:5.86–9.24) minutes for all MVPA 
bouts lasting 1 minute or more. Multivariate logistic regressions showed that participants undertaking 
≥150 minutes of MVPA per week were more likely to be successful agers with both self-reported (Odd 
Ratio (OR) = 1.29,95% (CI):1.09–1.53) and accelerometer data (length bout ≥1 minute:OR = 1.92, 
95%CI:1.60–2.30). Successful agers practice more MVPA, having both more short and long bouts, than 
non-successful agers.
More than one in ten adults globally is aged 60 years or older and this proportion is predicted to almost double by 
20501. Population ageing raises economic and societal challenges that stem from increased burden of multimor-
bidity and disability1. It also emphasizes the need for better understanding of preventive or curative strategies that 
would allow individuals to live free of disease longer and in good functional health2. Multiple risk and protective 
factors are associated with successful ageing3,4. One of them is physical activity4 which reduces risk of diabetes, 
cardiovascular diseases and cancers, and may also be neuroprotective2,5. The World Health Organization recom-
mends that older adults practice at least 150 minutes of moderate-to-vigorous physical activity (MVPA) per week, 
made up of bouts lasting a minimum 10 minutes6.
There is considerable evidence linking physical activity to successful ageing in cross-sectional7–9 and longitu-
dinal studies10–13. However, this evidence is based on self-reported physical activity which is prone to reporting 
biases. Recent studies using objective measures of physical activity, such as accelerometers, have mostly examined 
associations of health with total duration of physical activity. These studies found more physical activity14–16 or 
MVPA15,17 to be associated with favorable cardiometabolic outcomes18,19 and better motor15,16 and cognitive14,17 
function. There is also some evidence to suggest that time spent in both short and long MVPA bouts is associated 
with better cardio-metabolic health20–22 and reduced risk of multimorbidity23. However, the importance of phys-
ical activity patterns, such as the duration of physical activity bouts and their intensity, for successful ageing has 
not yet been examined.
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Our objective is to compare physical activity, assessed via questionnaire and accelerometer, between successful 
and non-successful agers using data from a well characterized cohort of community dwelling older adults, aged 60 
to 83 years. We also compared the proportion of successful agers in physical activity groups defined by duration 
in MVPA bouts, and length and intensity of MVPA bouts.
Methods
Study population. We used data from the Whitehall II cohort study, established in 1985/1988 on 10,308 
British civil servants (67% men) aged 35–55 years24. Informed consent was obtained from all participants. The 
study was approved by the ethics committee of University College London (reference number 85/0938) and con-
ducted in accordance with the 2008 Helsinki Declaration. The study design consists of a clinical examination 
every 3 to 6 years since study inception. Accelerometer measurement was added to the study at the 2012/2013 
wave of data collection for participants seen at the central London clinic and for those living in the South-Eastern 
regions of England who had their clinical assessment at home. For logistical reasons (charging and configuration 
of the devices), participants seen at home who resided in other parts of UK could not be offered the accelerometer 
measurement.
Whitehall II data, protocols, and other metadata are available to the scientific community. Please refer to the 
Whitehall II data sharing policy at http://www.ucl.ac.uk/whitehallII/data-sharing.
Physical Activity. Physical activity was assessed in 2012/2013 using questionnaire and accelerometer.
Questionnaire. Physical activity was assessed using a modified version of the validated Minnesota leisure-time 
physical activity questionnaire25,26, including 20-items on frequency and duration of participation in different 
physical activities (e.g., walking, cycling, sports). Participants were requested to take into account activity patterns 
over the past four weeks, at work and leisure. For each activity, including the open-ended items, we assigned a 
metabolic equivalent (MET) value by using the latest version of the compendium of activity energy costs27. One 
MET value reflects the intensity of the activity relative to lying quietly. All activities with MET values of 3 or above 
were coded as MVPA and summed to yield total numbers per week.
Accelerometer. At the clinical examination (on average 5 days after completion of the questionnaire), partici-
pants with no contraindications (allergies to plastic or metal, traveling abroad the following week) were asked to 
wear a triaxial accelerometer (GENEActiv Original; Activinsights Ltd, Kimbolton, Cambs, UK, http://www.gene-
activ.org/) on their non-dominant wrist for 9 consecutive, 24-hour, days. Acceleration was recorded at 85.7 Hz 
(corresponding to around 86 measurements per second) and as in previous studies using devices recording raw 
accelerometry28–31, acceleration was expressed relative to gravity (g units; 1 g = 9.81 m.s−2; 1 mg = 0.00981 m.s−2)). 
Calibration error was estimated based on static periods in the data and corrected if necessary (calibration cor-
rection range = 0.8 to 10.0 mg, mean correction = 2.5 mg)32. Next, the Euclidean Norm Minus One (ENMO), 
was used to quantify the acceleration related to the movement registered and expressed in milligravity (mg)33. 
Negative values were rounded to zero and ENMO values averaged over 5 second epochs.
As part of the accelerometer measurement, sleep periods were detected using a previously validated algo-
rithm34. Data from the first waking to waking on the penultimate day were extracted, corresponding to 7 full days. 
For the present analysis, only data over the day (periods between waking and sleep onset) were used. Participants 
were included in the analysis if they had valid data, defined as daily wear time ≥ 2/3 of waking hours, for at least 
2 weekdays and 2 week-end days. Non-wear time was estimated using a previously reported algorithm33 and was 
replaced by personalized mean value for each participant, calculated from their data on other days at the same 
time of day31,35.
In order for physical activity to be classified as MVPA, mean acceleration in the 5s-epoch (ENMO) needed 
to be at or above 100 mg28–30,36,37. To remove signals related to random wrist movement, we only retained activ-
ities lasting at least 1 minute for which 80% of the activity satisfied the 100 mg threshold criteria. In order to 
test the importance of length of a bout of physical activity, we identified bouts lasting 1 to 9 minutes 59 sec-
onds and those lasting 10 minutes or more, hereafter labeled “short” and “long” bouts20,21 (further details in 
Supplementary Methods). Time spent in MVPA bouts lasting 1 minute or more was calculated as the sum of 
short and long bouts. The daily accelerometer-assessed time in MVPA over a week was calculated as the mean 
of measures over 7 days. For participants with less than 7 valid days of data, the following formula was used to 
standardize measurement to one week for all participants: [(5 × mean daily weekday MVPA time + 2 × mean 
daily week-end MVPA time)]/7. Accelerometer data were processed in R using the GGIR package (cran.r-project.
org/web/packages/GGIR/index.html).
Assessment of successful ageing. We used data from the study baseline (1985/1988) to 2012/2013 to 
ascertain successful ageing. As in previous studies, we used a comprehensive definition of successful ageing that 
included better function (free of disability, good mental health and better cognitive, motor and respiratory func-
tion) and absence of major chronic disease (coronary artery disease, stroke, diabetes, cancer and neurodegenera-
tive disease)13,38. Chronic diseases were assessed from 1985/1988 to 2012/2013. Coronary heart disease, including 
myocardial infarction and definite angina, and stroke events were identified using linkage to national hospi-
tal records. Diabetes mellitus was defined as fasting blood glucose level of 7.0 mmol/L or more, HbA1c ≥ 6.5% 
(48 mmol/mol) based on blood sample assessed at the clinical examination, self-reported doctor-diagnosed dia-
betes, or the use of medications for diabetes. Cases of cancer were determined using the National Health Service’s 
cancer register. Neurodegenerative diseases included Parkinson’s disease and dementia and were assessed using 
linkage to national hospital records and mental health service dataset.
www.nature.com/scientificreports/
3Scientific RepoRts | 7:45772 | DOI: 10.1038/srep45772
Functioning outcomes were assessed at the 2012/2013 wave of data collection. Disability was assessed based 
on participants’ responses to 6 questions on perceived difficulties in basic activities of daily living lasting for at 
least 3 months (dressing, walking, bathing/showering, eating, getting in or out of bed, using the toilet), with 
difficulties in one or more activities taken to signal disability. Mental health was assessed using the Center for 
Epidemiologic Studies Depression Scale questionnaire, a 20-items questionnaire designed to assess prevalence of 
depressive symptoms39, with scores below the threshold of 16 seen to indicate good mental health39. We defined 
better cognitive, motor and respiratory functioning as scores above the sex- and age-standardized tertile (i.e. 
above the 33.3th percentile) for each measure. Cognitive functioning was assessed using a score of global cogni-
tion calculated as a standardized score of performances in 4 cognitive domains (short-term memory, attention 
(Trail-Making Test A), executive function (composite score of the Alice-Heim 4 and the Trail-Making Test B) 
and fluency (semantic and phonemic fluency tests)); motor function using walking speed measured over an 
8-footlong course and respiratory function using forced expiratory volume in 1 second (FEV1) divided by height 
squared.
Covariates. Sociodemographic variables were assessed by questionnaire in 2012/2013 and included age, sex, 
ethnicity (white and non-white), occupational position at age 50 years (high, intermediate or low, representing 
income and status at work) and education (university degree or lower). Health behaviours were also assessed 
by questionnaire. Smoking status was defined as current, past, and never smokers. Alcohol consumption was 
assessed using a question on the quantity of alcohol consumed in the previous week and was classified as no 
alcohol consumption in the previous week, moderate alcohol consumption (1–14 units/week in women and 
1–21 units/week in men), and heavy drinkers (14 + units in women and 21 + units in men). The frequency of 
fruit and vegetable consumption was assessed on a 9- point scale, ranging from “seldom or never” to “4 or more 
times a day”, and was categorized as less than daily, once per day, or more than once per day. Season of data col-
lection via accelerometer for each participant (winter: 21st of December to 20th of March, spring: 21st of March to 
20th of June, summer: 21st of June to 20th of September, and autumn: 21st of September to 20th of December) was 
also included as a covariate.
Statistical analyses. Two sets of analyses were undertaken. One, multivariate linear regression was used 
to compare mean MVPA duration (dependent variable) between successful agers and all others (independent 
variables). These analyses were repeated to study differences in mean acceleration, a measure of intensity, during 
MVPA bouts. Two, in order to compare the proportion of successful agers in different groups of physical activity 
patterns, the association of different physical activity characteristics (independent variable) with successful ageing 
(dependent variable) was examined using multivariate logistic regression and results expressed as odds ratios 
(OR) with 95% confidence intervals (CI). We used cubic splines to explore the shape of the association between 
MVPA and odds of successful ageing. All analyses, apart from the spline regressions, were adjusted for age, sex, 
ethnicity, education, smoking status, alcohol consumption, fruit and vegetable consumption, season and accel-
erometer wear time, with variables entered as categories as described in the Covariates section, apart from age 
which was entered as a continuous variable.
Sensitivity analyses were conducted to assess whether: 1) associations with MVPA were similar for compo-
nents used to construct the successful ageing phenotype; 2) findings were similar when a more stringent cut-off of 
120 mg was used to define MVPA using accelerometer data; 3) study findings could be explained partly by reverse 
causation by excluding from the analysis participants with disability and those who died within two years of the 
2012/2013 data collection.
For all analyses, the statistical significance level was set at 0.05 and all tests were two-sided. We used Stata 13 
(StataCorp LP, College Station, TX) for cubic splines regression and graphics; all others statistical analyses were 
performed using SAS software (version 9.4, SAS Institute Inc., Cary, NC, USA).
Results
Population selection. Of the 6,308 participants seen at the 2012–2013 wave of data collection, accelerome-
ters were proposed to 4,880 participants (4,680 seen at the London clinic and 200 at home). Among them, 210 had 
contraindications, 4,282 (87.7%) consented, and 3,953 participants had valid accelerometer data. Data on physical 
activity questionnaire were available for 3,929 of these participants. In addition, chronic disease and functioning 
measurements for the successful ageing outcome were available on 3,773 of these participants. In total, 3,749 
participants had information on successful ageing status, accelerometer and questionnaire physical activity data 
and covariates (flow chart in Supplementary Figure S1).
Compared to those not included in the analysis (n = 2,559), the analytic sample included participants who 
were younger (69.4 vs. 70.6 years, P < 0.001), more likely to be men (74.1% vs. 65.0%, P < 0.001) or from the low-
est occupational position (10.8% vs. 15.8%, P < 0.001). The participants included in the analysis were also more 
likely to report ≥ 150 minutes of MVPA per week (52.7% vs. 47.6%, P < 0.001) and to qualify as successful agers 
(21.1% vs. 13.0%, P < 0.001).
Study population characteristics. Among participants included in the analysis, 96.1% (N = 3,603) had 
valid accelerometer data for 7 days, 2.6% (N = 98) for 6 days, and 1.3% (N = 48) for 4–5 days. Missing data were 
replaced for 1–2 hours over the full observational period for 24.6% of the participants, 2–5 hours for 0.9% of the 
participants, 5–10 hours for 0.6% of the participants, and 10–25 hours for 0.1% of the participants. Table 1 pre-
sents characteristics of the study population. Spearman correlation coefficients of time spent in MVPA assessed 
by questionnaire with time spent in accelerometer-assessed MVPA short, long and ≥ 1 minute bouts were: 0.24 
(p < 0.001), 0.24 (p < 0.001), and 0.27 (p < 0.001), respectively.
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Physical activity in successful agers and the others. Overall, successful agers practiced more MVPA 
than all others (unadjusted models, all p < 0.0001, Table 1). Linear multivariate regression showed successful 
agers to report 3.79 (95% CI: 1.39, 6.19) minutes more MVPA. Accelerometer data suggested this difference to be 
3.40 (95% CI: 2.44, 4.35) minutes for MVPA undertaken in short bouts, 4.16 (95% CI: 3.11, 5.20) minutes for long 
bouts and 7.55 (95% CI: 5.86, 9.24) minutes for all MVPA in bouts of 1 minute or more. In addition, the intensity 
of MVPA as measured by mean acceleration of MVPA bouts was higher in successful agers than in the others 
(mean ENMO difference = 8.75 mg; 95% CI: 5.65, 11.85). This difference corresponds to 22% of the standard 
deviation of mean acceleration of MVPA bouts in the study sample.
Proportion of successful agers by physical activity group. Figure 1 shows the probability of successful 
ageing to be higher with increasing time spent in MVPA albeit with a plateauing of effects at longer durations; associ-
ations were stronger using accelerometer- than questionnaire-assessed MVPA. This general pattern was also observed 
for proportion of successful agers by categories of time spent in MVPA (Table 2). Accelerometer data show that in those 
Successful agers Unsuccessful agers
P (chi-2 or t-test)N (%) N (%)
N 789 (21.1) 2,960 (79.9)
Age (years), M(SD) 68.2 (5.4) 69.7 (5.7) < 0.0001
Women 212 (26.9) 741 (25.0) 0.29
Ethnicity (White) 786 (99.6) 2,690 (90.9) < 0.0001
High Occupational position at age 50y 464 (58.8) 1,196 (40.4) < 0.0001
University or higher 314 (39.8) 827 (27.9) < 0.0001
Smoking
 Current 21 (2.7) 186 (6.3) < 0.0001
 Ex 343 (43.5) 1,374 (46.4)
 Never 425 (53.9) 1,400 (47.3)
Alcohol
 None 110 (13.9) 633 (21.4) < 0.0001
 Moderate 552 (70.0) 1,925 (65.0)
 High 127 (16.1) 402 (13.6)
Fruit and vegetable consumption
 Less than daily 116 (14.7) 654 (22.1) < 0.0001
 Daily 139 (17.6) 664 (22.4)
 At least twice daily 534 (67.7) 1,642 (55.5)
Minutes per day of MVPA, M(SD)
 Assessed by questionnaire 35.5 (34.0) 29.2 (30.3) < 0.0001
 Assessed by accelerometer 
  MVPA 1 + min bouts 34.9 (25.7) 24.5 (21.6) < 0.0001
  MVPA 10 + min bouts 13.3 (18.3) 7.6 (11.9) < 0.0001
150 minutes per week of MVPA
 Assessed by questionnaire 479 (60.7) 1,487 (50.5) < 0.0001
 Assessed by accelerometer 
  MVPA 1 + min bouts 518 (65.7) 1,345 (45.4) < 0.0001
  MVPA 10 + min bouts 149 (18.9) 283 (9.6) < 0.0001
Acceleration of MVPA 1 + min bouts, M(SD) 186.3 (46.8) 175.8 (36.9) < 0.0001
Chronic diseases
 CHD 0 572 (19.3)
 Stroke 0 40 (1.4)
 Diabetes 0 469 (16.3)
 Cancer 0 528 (17.9)
 Neurodegenerative diseases 0 24 (0.8)
Functioning
 No disability 789 (100) 2,551 (87.4)
 Standardized cognitive score, M(SD) 0.6 (0.6) − 0.1 (1.0)
 Walking speed (m/s), M(SD) 1.3 (0.2) 1.1 (0.3)
 FEV1/height2 (L/m2), M(SD) 1.1 (0.2) 0.9 (0.2)
 Good mental health (CESD < 16) 789 (100) 2,378 (85.7)
Table 1.  Characteristics of the study population.
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with daily duration of MVPA < 10 min, the prevalence of successful ageing was 9.3%; this rose to 29.5% in those with 
30 min of MVPA or more per day. The corresponding estimates for questionnaire data were 14.9 and 25.8%.
Short and long bouts as defined by accelerometer data had a similar association with successful ageing: in mul-
tivariate logistic analyses, OR estimates for a 10-minute increase per day of MVPA undertaken in short and long 
bouts were 1.17 (95% CI: 1.09, 1.26) and 1.15 (95% CI: 1.08, 1.22), respectively (Table 2). This led us to use MVPA 
bouts lasting 1 minute or more as the bout metric in subsequent analysis. For every 10-minute increase in MVPA 
per day, the odds for successful ageing increased by 4% (95% CI: 2%, 7%) when using reported MVPA compared 
to 16% (95% CI: 12%, 20%) with accelerometer data – the non-overlapping confidence intervals suggest that 
the difference in ORs is statistically significant at p < 0.05. For accelerometer-assessed MVPA, 10–20 min and 
20–30 min of MVPA per day was associated with around 2.2–2.5-fold higher odds of successful ageing compared 
to < 10 min MVPA. Reanalysis using 10–20 min MVPA as the reference group showed 20 min or more of MVPA 
to be associated with 1.38 greater odds of successful ageing (95% CI: 1.12, 1.69).
Further analysis to test whether the pattern of MVPA mattered for those undertaking the recommended ≥ 
150 minutes of MVPA per week showed similar associations with successful ageing in those undertaking MVPA 
in bouts of 1 minute or more or 10 minutes or more (OR = 1.92, 95% CI: 1.60, 2.30 and 1.74, 95% CI: 1.38, 2.18 
respectively). The pattern was similar, albeit associations weaker, using questionnaire-assessed MVPA (OR = 1.29, 
95% CI: 1.09, 1.53, Table 2).
The odds ratio of successful ageing increased as the intensity of accelerometer assessed MVPA increased 
(OR = 1.16, 95% CI: 1.07, 1.26 for 1 SD (39.4 mg) higher acceleration). Compared to the first quartile of intensity, 
the 2nd, 3rd, and 4th quartile of MVPA intensity were associated with an OR of successful ageing of 1.50 (95% CI: 
1.17, 1.94), 1.42 (95% CI: 1.10, 1.84), and 1.75 (95% CI: 1.35, 2.27), respectively.
Sensitivity analyses. The associations between MVPA and successful ageing were also observed when 
chronic disease and functioning were considered as separate outcomes (Table 3). Apart from good mental health, 
MVPA was linked to all functioning components, with associations being stronger for absence of disability and 
Figure 1. Probability of successful ageing as a function of daily duration in MVPA. 








agers OR 95% CI
Daily duration of MVPA 
per 10 min increase 23.0 3,749 21.05 1.04 1.02, 1.07
 Short bouts — — — 15.7 3,749 21.05 1.17 1.09, 1.26
 Long bouts — — — 3.7 3,749 21.05 1.15 1.08, 1.22
 ≥ 1 min bouts — — — 21.3 3,749 21.05 1.16 1.12, 1.20
Daily duration of MVPA
 < 10 min 2.7 1,192 14.93 1 (Ref.) 4.8 912 9.32 1 (Ref.)
 10 to 20 min 15.0 558 22.04 1.46 1.12, 1.91 14.8 865 19.42 2.18 1.63, 2.91
 20 to 30 min 25.7 473 19.87 1.21 0.91, 1.62 24.5 682 22.87 2.47 1.83, 3.35
 ≥ 30 min per day 50.9 1,526 25.82 1.63 1.32, 2.02 45.0 1,290 29.46 3.32 2.51, 4.38
Recommendation of 150 min per week
 No 5.4 1,766 17.55 1 (Ref.) 10.4 1,886 14.37 1 (Ref.)
 Yes 42.9 1,966 24.36 1.29 1.09, 1.53 36.6 1,863 27.80 1.92 1.60, 2.30
Table 2.  Association between daily duration of MVPA and weekly recommendation with successful 
ageing.
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motor function (Table 3). For mental health, an association with MVPA was only observed for questionnaire 
data, possibly reflecting common method variance, and for long accelerometer-assessed bouts, possibly reflecting 
gains only over longer periods of MVPA. Associations with successful ageing and its components were similar 
when using the more stringent MVPA cut-point of 120 mg (Supplementary Table S1). Excluding participants 
who reported disability and those who died in two years following data collection from the analysis somewhat 
attenuated the associations in the main analysis (Supplementary Table S2).
Discussion
This study based on 3,749 adults aged 60 to 83 years presents three key findings. First, accelerometer data show 
that successful agers spend on average 8 minutes more per day in MVPA than their unhealthy counterparts; both 
longer daily duration and higher intensity of MVPA bouts were associated with greater probability of successful 
ageing. Second, associations between MVPA and successful ageing were stronger with physical activity assessed 
by accelerometer. Third, length of a bout of MVPA, short (1–9.59 min) or long (≥ 10 min), did not modify the 
association of MVPA with successful ageing.
Our data show the prevalence of successful ageing to be higher with longer duration of MVPA, with a weaken-
ing of the effect at daily durations longer than 20 or 30 minutes. Similar findings, albeit with questionnaire-assessed 
physical activity and a range of health outcomes, have been reported40–42. A recent meta-analysis concluded that 
although more total physical activity was associated with lower risk for breast and colon cancer, diabetes, ischemic 
heart disease, and ischemic stroke, major gains were observed at lower levels of activity, with diminishing returns 
at higher levels of activity42. For example, compared to less active participants (< 600 MET.minutes/week), the 
risk of colon cancer was reduced by 10%, 17% and 21% respectively in those reporting 600–3999, 4000–7999, and 
≥ 8000 MET.minutes/week. In our study, successful ageing was twice as likely for daily MVPA of 10 to 20 minutes, 
compared to less than 10 minutes. However, compared to 10 to 20 minutes per day of MVPA, successful ageing 
was only 38% more likely in those undertaking 20 to 30 minutes of MVPA per day. Our findings on MVPA 
intensity are concordant; with fewer benefices at higher intensity levels. This is in agreement with recent findings 
suggesting that even a little MVPA is good for successful ageing43.
Better functioning
No chronic 









OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
QUESTIONNAIRE ASSESSED PHYSICAL ACTIVITY
 Daily duration of MVPA 
per 10 min increase 1.03 (1.01–1.06) 1.05 (1.02–1.07) 1.12 (1.07–1.17) 1.01 (0.98–1.03) 1.08 (1.05–1.11) 1.04 (1.01–1.07) 1.13 (1.07–1.18)
 Daily duration of MVPA 
  < 10 min 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.)
  10 to 20 min 1.23 (0.98–1.53) 1.54 (1.21–1.97) 1.67 (1.19–2.33) 1.20 (0.94–1.53) 1.44 (1.15–1.80) 1.12 (0.89–1.42) 1.49 (1.08–2.05)
  20 to 30 min 1.04 (0.83–1.31) 1.34 (1.04–1.73) 1.61 (1.13–2.29 1.14 (0.88–1.47) 1.38 (1.09–1.75) 1.23 (0.95–1.58) 1.49 (1.06–2.10)
  ≥ 30 min per day 1.35 (1.13–1.60) 1.72 (1.42–2.08) 2.58 (1.95–3.41) 1.19 (0.98–1.44) 1.75 (1.46–2.09) 1.39 (1.16–1.68) 2.24 (1.70–2.94)
 Recommendation of 150 min per week 
  No 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.)
  Yes 1.15 (1.00–1.34) 1.35 (1.15–1.58) 1.92 (1.52–2.42) 1.10 (0.94–1.29) 1.43 (1.23–1.66) 1.29 (1.11–1.51) 1.72 (1.37–2.15)
ACCELEROMETER ASSESSED PHYSICAL ACTIVITY
 Daily duration of MVPA 
per 10 min increase 
  Short bouts 1.24 (1.16–1.34) 1.16 (1.08–1.24) 1.53 (1.34–1.76) 1.10 (1.03–1.19) 1.28 (1.19–1.38) 1.16 (1.08–1.24) 0.97 (0.88–1.08)
  Long bouts 1.06 (0.98–1.13) 1.13 (1.06–1.20) 1.15 (0.99–1.34) 1.01 (0.95–1.08) 1.12 (1.04–1.21) 1.06 (0.99–1.13) 1.12 (1.00–1.26)
  ≥ 1 min bouts 1.15 (1.10–1.19) 1.14 (1.10–1.18) 1.35 (1.25–1.47) 1.06 (1.02–1.10) 1.20 (1.15–1.25) 1.10 (1.06–1.15) 1.04 (0.99–1.10)
 Daily duration of MVPA bouts ≥1 min 
  < 10 min 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.)
  10 to 20 min 1.52 (1.25–1.86) 1.87 (1.46–2.39) 2.24 (1.68–2.99) 1.52 (1.21–1.90) 1.96 (1.59–2.41) 1.26 (1.01–1.57) 1.35 (0.99–1.85)
  20 to 30 min 1.63 (1.31–2.03) 2.51 (1.94–3.25) 4.21 (2.84–6.22) 1.53 (1.20–1.96) 2.06 (1.64–2.59) 1.72 (1.35–2.19) 1.38 (0.98–1.94)
  ≥ 30 min per day 2.30 (1.88–2.82) 2.71 (2.14–3.44) 3.87 (2.80–5.34) 1.67 (1.34–2.08) 3.08 (2.49–3.80) 1.68 (1.36–2.09) 1.32 (0.98–1.79)
Recommendation of 150 min per week 
 MVPA bouts ≥1 min
  No 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.)
  Yes 1.64 (1.41–1.90) 1.81 (1.54–2.13) 2.41 (1.87–3.10) 1.31 (1.11–1.54) 1.82 (1.56–2.13) 1.51 (1.29–1.77) 1.12 (0.89–1.41)
MVPA bouts ≥10 min
  No 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.)
  Yes 1.57 (1.23–2.01) 1.54 (1.24–1.92) 2.09 (1.29–3.38) 1.01 (0.79–1.29) 1.94 (1.50–2.52) 1.34 (1.05–1.71) 1.09 (0.75–1.57)
Table 3.  Association of daily duration and weekly recommendation of MVPA with components of 
successful ageing.
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Previous studies, based on cross-sectional or longitudinal designs, have found that longer self-reported 
duration in MVPA was associated with greater likelihood of successful ageing7,8,10–13,44. Our findings add to 
this evidence using data on both subjective and objective assessments of MVPA. We show that the association 
with successful ageing was more pronounced for MVPA assessed by accelerometer compared to questionnaire. 
Previous studies have also shown objective assessments of physical activity to be more strongly associated with 
metabolic syndrome45, biomarkers46 and obesity indicators37. Taken together these findings suggest that measure-
ment error inherent to self-reported physical activity measures leads to misclassification, attenuating associations 
with health outcomes47. In relation to successful ageing, it is possible that the compendium of physical activities, 
developed for adults up to 65 years, does not adequately reflect physical activity patterns of older adults.
Public health messages encourage people to undertake bouts of physical activity lasting a minimum of 10 min-
utes. However, bouts of less than 10 minutes are likely to be more achievable for older adults. We found asso-
ciations with successful ageing to be similar for MVPA bouts lasting less than 10 minutes and 10 minutes or 
more. Few previous studies reported similar association with time spent in short and long bouts of MVPA with 
cardio-metabolic outcomes20–22 and multimorbidity23. Indeed, bouts of MVPA of at least 10 minutes are recom-
mended for cardiorespiratory fitness6,48, although appropriate experimental studies to assess associations between 
duration spent in different lengths of MVPA bouts and health outcomes are lacking48.
Strengths of this study include its large study sample, the use of both questionnaire- and accelerometer-assessed 
physical activity, and high compliance for accelerometer wear among participants. Cross-sectional design is a 
limitation, precluding inferences about temporality, such as whether physical activity preceded successful ageing 
or was preceded by successful ageing. However, sensitivity analyses excluding participants with disability and 
those who died in 2 years after data collection suggest that our findings cannot be entirely explained by reduced 
physical activity in already sick participants. Furthermore, we have previously used longitudinal data, using 
questionnaire-assessed MVPA, to show an association of physical activity with successful ageing13. Future lon-
gitudinal studies using accelerometers are needed to confirm the findings in the present study. Second, although 
the sample covered a wide socioeconomic range, data are from an occupational cohort and are not representative 
of the general population (i.e. composed of more men and highly educated participants). In addition, the analytic 
sample was composed of the more physically active participants, who were more likely to age successfully. Taken 
together, these aspects would lead to be an underestimation of the association between MVPA and successful 
ageing.
In conclusion, accelerometer data from a large sample of UK older adults suggest that successful agers prac-
ticed MVPA for longer duration and at higher intensity. Higher proportion of successful agers was also observed 
in those practicing more MVPA, independently of the length of the MVPA bout. Future studies using a longitu-
dinal design should examine whether physical activity predicts successful ageing over time.
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